天花治療市場：依治療類型、給藥途徑、分銷管道和地區分類

Smallpox Treatment Market, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，2026年天花治療市場價值為7,250萬美元，預計到2033年將達到8,500萬美元。預計從2026年到2033年，其複合年成長率將達到2.3%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	7250萬美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	2.30%	2033年市場規模預測：	8500萬美元

天花是由天花病毒引起的急性傳染病，該病毒屬於正痘病毒科。目前尚無針對天花的特效藥，但如果在接觸病毒後四天內接種疫苗，可以有效預防感染。目前尚無已知的天花特異性，但研究人員正在努力開發能夠殺死病毒的藥物。

市場動態：

天花負擔日益加重、對安全有效療法的需求不斷成長、對研發安全有效疫苗的重視程度提高以及政府的支持，這些因素預計將推動全球天花治療市場的成長。

例如，2021年6月，美國食品藥物管理局（FDA）批准了由美國生物製藥公司Chimerix Inc.生產的brincidofovir（BCV，商品名Tembexa）用於治療天花。 FDA依據「動物規則」批准了Tembexa，該規則允許在不切實際或存在倫理問題的情況下，使用經過適當控制的動物進行的療效研究結果作為批准的依據。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數，介紹了全球天花治療市場主要參與者的概況。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份《全球天花治療市場》報告旨在為產業內的各類相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用全球天花治療市場分析中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

SIGA Technologies, Inc.
Bavarian Nordic A/S
Emergent BioSolutions Inc.
GlaxoSmithKline plc
Sanofi
Merck & Co., Inc.
Pfizer Inc.
Bharat Biotech International Ltd.
Chimerix, Inc.

第10章

調查方法
關於本公司

簡介目錄

Product Code: CMI5800

Smallpox Treatment Market is estimated to be valued at USD 72.5 Mn in 2026 and is expected to reach USD 85.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 2.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 72.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	2.30%	2033 Value Projection:	USD 85.0 Mn

Smallpox is an acute contagious disease caused by the variola virus, a member of the orthopoxvirus family. There is no cure for smallpox, but vaccination can be used effectively to prevent infection from developing if given during a period of up to four days after a person has been exposed to the virus. There is no known specific treatment for smallpox, although research is being carried out in an attempt to create a medication capable of killing the virus.

Market Dynamics:

A rise in the burden of smallpox, growing demand for safe and effective treatment, a rise in focus on the development of safe and effective vaccines, and favorable government initiatives are major factors expected to propel the growth of the global smallpox treatment market.

For instance, in June 2021, the U.S. Food and Drug Administration (FDA) approved brincidofovir (BCV, Tembexa,) which is manufactured by Chimerix Inc., a U.S.-based biopharmaceutical company, to treat smallpox. The FDA approved Tembexa under the agency's Animal Rule, which allows findings from adequate and well-controlled animal efficacy studies to serve as the basis of approval when it is not feasible or ethical to conduct efficacy trials in humans.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global smallpox treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include SIGA Technologies, Inc., Bavarian Nordic A/S, Emergent BioSolutions Inc., GlaxoSmithKline plc, Sanofi, Merck & Co., Inc., Pfizer Inc., Bharat Biotech International Ltd. and Chimerix, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global smallpox treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smallpox treatment market.

Smallpox Treatment Market Detailed Segmentation:

By Treatment Type (Revenue, USD Mn, 2021 - 2033)
Antiviral Drugs
Vaccination
Supportive Care
By Route of Administration (Revenue, USD Mn, 2021 - 2033)
Oral
Injectable
Others (Topical, etc.)
By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
Hospitals
- Public
- Private
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles:
SIGA Technologies, Inc.
Bavarian Nordic A/S
Emergent BioSolutions Inc.
GlaxoSmithKline plc
Sanofi
Merck & Co., Inc.
Pfizer Inc.
Bharat Biotech International Ltd.
Chimerix, Inc.

Market Dynamics
- Increasing government funding and initiatives for research of antiviral medication
- Awareness and education about smallpox
- Rising geriatric population.
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER€(TM)s Analysis
Epidemiology
Merger and Acquisition Scenario

4. Smallpox Treatment

Supply Side and Demand Side Analysis
Economic Impact

5. Smallpox Treatment Market, By Treatment Type, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Antiviral Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Vaccination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Supportive Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Smallpox Treatment Market, By Route of Administration, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Others (Topical, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

7. Smallpox Treatment Market, By Distribution Channel, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  - Public
  - Private
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

8. Smallpox Treatment Market, By Region, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

SIGA Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bavarian Nordic A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Emergent BioSolutions Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bharat Biotech International Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Chimerix, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views